Literature DB >> 10197770

Descending modulation of opioid-containing nociceptive neurons in rats with peripheral inflammation and hyperalgesia.

L MacArthur1, K Ren, E Pfaffenroth, E Franklin, M A Ruda.   

Abstract

Inflammation and hyperalgesia induce a dramatic up-regulation of opioid messenger RNA and peptide levels in nociceptive neurons of the spinal dorsal horn. Descending axons modulate nociceptive transmission at the spinal level during inflammatory pain, and may play a role in the development of persistent pain. The role of descending bulbospinal pathways in opioid-containing nociceptive neurons was examined. Removal of descending inputs to the spinal cord was performed by complete spinal transection at the midthoracic level. Seven days after spinal transection, rats received a unilateral hindpaw injection of complete Freund's adjuvant, a noxious stimulus that produces inflammation and hyperalgesia. Tissues from the L4 and L5 segments of the spinal cord were removed and analysed by northern blotting and immunocytochemistry. Spinal transection resulted in a further increase in both dynorphin and enkephalin messenger RNA content following complete Freund's adjuvant injection. There was a similar distribution and number of dynorphin-immunoreactive cells in transected rats compared to rats which received sham surgery. These data suggest that increased dynorphin messenger RNA ipsilateral to inflammation, in rats without descending axons, was due to increased expression within the same cells and not to recruitment of additional dynorphin-expressing cells. This reflects a greater dynamic response of nociceptive neurons to noxious stimuli in the absence of descending modulation. Therefore, the net effect of descending afferents on spinal nociceptive circuits may be to reduce the response of opioid-containing neurons to noxious stimulation from the periphery.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10197770     DOI: 10.1016/s0306-4522(98)00204-8

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  11 in total

1.  The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation.

Authors:  R W Hurley; D L Hammond
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

2.  Differential involvement of trigeminal transition zone and laminated subnucleus caudalis in orofacial deep and cutaneous hyperalgesia: the effects of interleukin-10 and glial inhibitors.

Authors:  Kohei Shimizu; Wei Guo; Hu Wang; Shiping Zou; Stacey C LaGraize; Koichi Iwata; Feng Wei; Ronald Dubner; Ke Ren
Journal:  Mol Pain       Date:  2009-12-21       Impact factor: 3.395

3.  Peptidases prevent mu-opioid receptor internalization in dorsal horn neurons by endogenously released opioids.

Authors:  Bingbing Song; Juan Carlos G Marvizón
Journal:  J Neurosci       Date:  2003-03-01       Impact factor: 6.167

4.  Contribution of endogenous enkephalins to the enhanced analgesic effects of supraspinal mu opioid receptor agonists after inflammatory injury.

Authors:  R W Hurley; D L Hammond
Journal:  J Neurosci       Date:  2001-04-01       Impact factor: 6.167

5.  Acute inflammation induces segmental, bilateral, supraspinally mediated opioid release in the rat spinal cord, as measured by mu-opioid receptor internalization.

Authors:  W Chen; J C G Marvizón
Journal:  Neuroscience       Date:  2009-03-17       Impact factor: 3.590

6.  Gene expression profiling of mouse bladder inflammatory responses to LPS, substance P, and antigen-stimulation.

Authors:  Marcia R Saban; Ngoc-Bich Nguyen; Timothy G Hammond; Ricardo Saban
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

7.  Inflammation-induced enhancement of the visceromotor reflex to urinary bladder distention: modulation by endogenous opioids and the effects of early-in-life experience with bladder inflammation.

Authors:  Jennifer DeBerry; Timothy J Ness; Meredith T Robbins; Alan Randich
Journal:  J Pain       Date:  2007-08-20       Impact factor: 5.820

8.  Electroacupuncture attenuates bone-cancer-induced hyperalgesia and inhibits spinal preprodynorphin expression in a rat model.

Authors:  Rui-Xin Zhang; Aihui Li; Bing Liu; Linbo Wang; Jiajia Xin; Ke Ren; Jian-Tian Qiao; Brian M Berman; Lixing Lao
Journal:  Eur J Pain       Date:  2008-01-24       Impact factor: 3.931

9.  Comparing analgesia and mu-opioid receptor internalization produced by intrathecal enkephalin: requirement for peptidase inhibition.

Authors:  Wenling Chen; Bingbing Song; Lijun Lao; Orlando A Pérez; Woojae Kim; Juan Carlos G Marvizón
Journal:  Neuropharmacology       Date:  2007-08-02       Impact factor: 5.250

10.  Endogenous kappa-opioid receptor systems inhibit hyperalgesia associated with localized peripheral inflammation.

Authors:  R J Schepers; Janet Lynn Mahoney; Brenda Jean Gehrke; Toni Shaun Shippenberg
Journal:  Pain       Date:  2008-03-19       Impact factor: 7.926

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.